Prices delayed by at least 15 minutes | Print
iRadimed Corp (IRMD)
Common SharesOpen
$43.93
Previous close
$43.59
Trade high
$44.03
Volume
51,873
Year high
$51.04
Year low
$36.12
Dividend yield
0.34%
Market capitalisation
$553.30 mn
P/E ratio
31.14
ISIN
US46266A1097
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 22/12/2023 | 20/05/2024 |
Ex-dividend date | 21/12/2023 | 17/05/2024 |
Payment date | 12/01/2024 | 30/05/2024 |
Amount | $0.15 | $0.15 |
Company profile
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.